|
Research Management and Support
|
RMS ES 2018
|
$340,640,887
|
$108,000
|
N/A
|
National Institutes of Health
|
|
Cancer Center Support Grant
|
3P30CA013696-43S1
|
$120,000
|
$12,000
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S2
|
$60,000
|
$6,000
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S3
|
$118,652
|
$11,865
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Development of personalized surgical algorithms for muscle-invasive bladder cancer patients
|
1R21CA218976-01
|
$199,013
|
|
ABBOSH, PHILIP
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Sphingolipid Signaling in Mammals
|
ZIA BC 011187
|
$679,649
|
$679,649
|
Acharya, Jairaj
|
CCR (NCI)
|
|
DEVELOPMENT OF GOGGLE SYSTEM FOR FLUORESCENCE IMAGE-GUIDED SURGERY
|
3R01CA171651-05S1
|
$46,696
|
|
ACHILEFU, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
Center for Multiple Myeloma Nanotherapy
|
3U54CA199092-03S1
|
$29,864
|
|
ACHILEFU, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
Nanoparticle mediated microenvironmental targeting of CCL3 signaling for the treatment of acute myelogenous leukemia
|
1F31CA228391-01
|
$42,418
|
$13,998
|
ACKUN-FARMMER, MARIAN
|
UNIVERSITY OF ROCHESTER
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-05S1
|
$2,256,906
|
$756,064
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Discovery and Characterization of Mutations in Breast and Ovarian Cancers
|
5R50CA211280-02
|
$215,047
|
|
ADAMSON, AARON
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-05
|
$20,853,800
|
$6,986,023
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Probing the role of the IRE1alpha-XBP1 pathway in normal and malignant hematopoiesis
|
1K22CA218467-01
|
$192,575
|
|
ADORO, STANLEY
|
CASE WESTERN RESERVE UNIVERSITY
|
|
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities (1 of 3)
|
5U54CA163069-07
|
$1,414,315
|
|
ADUNYAH, SAMUEL
|
MEHARRY MEDICAL COLLEGE
|
|
Developing targeted activatable peptides to amplify radiosensitizer delivery
|
1R03CA219744-01
|
$77,500
|
|
ADVANI, SUNIL
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Novel Combinatorial Therapeutic Approach for Prostate Cancer
|
1R03CA219336-01
|
$74,250
|
|
AFAQ, FARRUKH
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Leveraging polyamine metabolic stress as a novel therapy for prostate cancer
|
5F99CA212455-02
|
$29,518
|
|
AFFRONTI, HAYLEY
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Functional interrogation of epigenetic vulnerabilities in KRAS-mutant pancreatic cancer
|
1K08CA218420-01
|
$177,120
|
|
AGUIRRE, ANDREW
|
DANA-FARBER CANCER INST
|
|
Epigenetic and microenvironmental regulation of dormant disseminated cancer
|
1R01CA218024-01
|
$445,511
|
|
AGUIRRE-GHISO, JULIO
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Modulating systemic pro-oncogenic effects of focal image-guided tumor ablation
|
5R01CA197081-02
|
$474,276
|
|
AHMED, MUNEEB
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Bangladesh Center for Research Excellence in Non-Communicable Disease
|
5P20CA210305-02
|
$254,168
|
|
AHSAN, HABIBUL
|
UNIVERSITY OF CHICAGO
|
|
The role of the SCF/FBW7 ubiquitin ligase complex in hematopiesis and leukemia.
|
5R01CA133379-10
|
$381,375
|
$190,688
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Long non-coding RNAs in hematopoiesis and blood malignancy
|
5R01CA194923-04
|
$457,533
|
$228,767
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Mapping cancer micro-environments for acute leukemia
|
5R01CA202025-03
|
$455,870
|
$227,935
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Dr. Keiko Akagi, A Bioinformatics Specialist in Cancer Genomics Research at OSU Comprehensive Cancer Center
|
7R50CA211533-02
|
$122,475
|
|
AKAGI, KEIKO
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Integrated analysis of protein expression data from the Reverse Phase Protein Array (RPPA) platform
|
5U24CA210950-02
|
$413,299
|
|
AKBANI, REHAN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
MULTIMODAL PRECLINICAL CANCER IMAGING AND THERAPY RESEARCH SPECIALIST
|
5R50CA211481-03
|
$170,003
|
|
AKERS, WALTER
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Metabolic Syndrome and Epigenetic Markers of Breast Cancer in Nigerian Women
|
K01TW010271-02
|
$134,531
|
|
Akinyemiju, Tomi
|
UNIVERSITY OF KENTUCKY
|
|
Cancer Prevention and Control Health Disparities Training Program
|
5T32CA078447-17
|
$244,074
|
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
A collaborative structural hub to promote Cancer Center science and drug design
|
5R50CA211440-02
|
$145,562
|
|
ALESHIN, ALEXANDER
|
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST
|
|
A low-cost automated Gallium-68 drug preparation device for diagnostic PET imaging
|
1R43CA217425-01
|
$225,000
|
|
ALEXOFF, DAVID
|
FIVE ELEVEN PHARMA, INC.
|
|
Cancer Related Health Disparities Training Program
|
5T32CA163184-07
|
$294,488
|
|
ALLEN, MICHELE
|
UNIVERSITY OF MINNESOTA
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144 07130
|
$1,652,758
|
$1,652,758
|
Alter, Blanche
|
DCEG (NCI)
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-48S1
|
$142,498
|
$2,850
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Discovery of Novel Therapeutics for Glioblastoma
|
1R43CA213695-01A1
|
$300,000
|
|
ALTON, GORDON
|
CURTANA PHARMACEUTICALS, INC.
|
|
Epidemiology of Breast Cancer Subtypes in African American Women: a Consortium
|
3P01CA151135-05S1
|
$300,001
|
|
AMBROSONE, CHRISTINE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$753,084
|
$37,654
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Effects of Physical Activity Calorie Expenditure (PACE) Food Labeling
|
3R01CA184473-04S1
|
$45,615
|
|
AMMERMAN, ALICE
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Coordinating Center: Molecular and Cellular Findings of Screen-Detected Lesions
|
3U01CA196386-03S1
|
$559,564
|
|
AMOS, CHRISTOPHER
|
DARTMOUTH COLLEGE
|
|
Women's Health Initiative Cancer Survivor Cohort
|
3UM1CA173642-05S1
|
$56,922
|
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Women's Health Initiative Cancer Survivor Cohort
|
3UM1CA173642-05S2
|
$165,708
|
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Performance, safety, and efficacy of a new cyrotherapy device for cervical dyspla
|
5UH3CA189923-04
|
$903,888
|
|
ANDERSON, JEAN
|
JOHNS HOPKINS UNIVERSITY
|
|
Disruption of T cell tolerance in type 1 diabetes
|
P01AI118688-02S1
|
$47,714
|
|
Anderson, Mark
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Targeting the adenosine A2A receptor immune checkpoint in lung cancer patients
|
5R01CA201124-02
|
$259,646
|
|
ANTONIA, SCOTT
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Collaborative Pathways that Lead to Leukemia
|
ZIA BC 010982
|
$437,122
|
$437,122
|
Aplan, Peter
|
CCR (NCI)
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
ZIA SC 010378
|
$374,676
|
$187,338
|
Aplan, Peter
|
CCR (NCI)
|
|
Mechanisms of Chromosomal Translocation
|
ZIA SC 010379
|
$62,446
|
$12,489
|
Aplan, Peter
|
CCR (NCI)
|
|
COMPRENDO: Adaptation and Implementation of a Peer-Navigation Intervention to Improve Research Literacy and Diversity in Pediatric Leukemia Clinical Trials
|
1K08CA230306-01
|
$254,821
|
$254,821
|
ARISTIZABAL, PAULA
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
Targeting DOT1L for Degradation in MLL-rearranged Leukemia
|
2R01CA176745-07
|
$404,076
|
$404,076
|
ARMSTRONG, SCOTT
|
DANA-FARBER CANCER INST
|
|
Childhood Cancer Survivor Study
|
3U24CA055727-24S1
|
$120,439
|
$24,088
|
ARMSTRONG, GREGORY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
Total relevant funding to Childhood Leukemia for this search: $89,672,408
|